Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Mobilization of CD8 + Central Memory T-Cells with Enhanced Reconstitution Potential in Mice By a Combination of G-CSF and GMI-1271-Mediated E-Selectin Blockade

Ingrid G Winkler, PhD, Valerie Barbier, Kristen J Radford, PhD, Julie M Davies, PhD, Jean-Pierre Levesque, PhD, Theodore A.G. Smith, PhD, William E. Fogler, PhD, John L Magnani, PhD

Blood (2015) 126 (23): 512.

https://doi.org/10.1182/blood.V126.23.512.512

Published: 2015

Journal Articles

Residual Lymphocytes in GM-CSF and IL-15 Differentiated Monocyte-Derived Dendritic Cells Enables Cytotoxic T Lymphocyte Responses.

Melinda Y. Hardy, BSc (Hons), Andrew J. Kassianos, BSc (Hons), Ray Wilkinson, PhD, Annelie Vulink, MD, Derek N.J. Hart, PhD, MD, Kristen J. Radford, PhD

Blood (2007) 110 (11): 4907.

https://doi.org/10.1182/blood.V110.11.4907.4907

Published: 2007

Journal Articles

HuMax-CD20, a Novel Fully Human Anti-CD20 Monoclonal Antibody: Results of a Phase I/II Trial in Relapsed or Refractory Follicular Non-Hodgkins’s Lymphoma.

A. Hagenbeek, T. Plesner, P. Johnson, L. Pedersen, J. Walewski, A. Hellmann, B. Link, T. Robak, M. Wojtukiewicz, M. Pfreundschuh, M. Kneba, A. Engert, P. Sonneveld, J. Petersen, J. Radford

Blood (2005) 106 (11): 4760.

https://doi.org/10.1182/blood.V106.11.4760.4760

Published: 2005

Journal Articles

HuMax-CD4 (Zanolimumab), a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in CD4 + Peripheral T-Cell Lymphoma of Non-Cutaneous Type.

Francesco d’Amore, T. Relander, H. Hagberg, A. Osterborg, M. Hansen, L. Moeller, P. Johnson, J. Radford, B. Hancock, M. Gramatzki, S. Krause, M. Dreyling, N. Schmitz, S. Lisby, O. Baadsgaard

Blood (2005) 106 (11): 3354.

https://doi.org/10.1182/blood.V106.11.3354.3354

Published: 2005

Journal Articles

Assessing the Predictive Value of Plasma FLT3-L Levels for Hematologic Toxicity after Yttrium-90 Ibritumomab Tiuxetan ([ 90 Y]-Zevalin) Given as Consolidation in Patients with Advanced B-Cell Follicular NHL Responding to First Line Therapy.

F. Morschhauser, J. Radford, A. van Hoof, I. Kuss, A. Chlistalla, A. Hagenbeek

Blood (2005) 106 (11): 4795.

https://doi.org/10.1182/blood.V106.11.4795.4795

Published: 2005

Journal Articles

Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture

LH Coutinho, A Will, J Radford, R Schiro, NG Testa, TM Dexter

Blood (1990) 75 (11): 2118–2129.

https://doi.org/10.1182/blood.V75.11.2118.2118

Published: 1990

NARROW

Mobilization of CD8 + Central Memory T-Cells with Enhanced Reconstitution Potential in Mice By a Combination of G-CSF and GMI-1271-Mediated E-Selectin Blockade

Residual Lymphocytes in GM-CSF and IL-15 Differentiated Monocyte-Derived Dendritic Cells Enables Cytotoxic T Lymphocyte Responses.

HuMax-CD20, a Novel Fully Human Anti-CD20 Monoclonal Antibody: Results of a Phase I/II Trial in Relapsed or Refractory Follicular Non-Hodgkins’s Lymphoma.

HuMax-CD4 (Zanolimumab), a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in CD4 + Peripheral T-Cell Lymphoma of Non-Cutaneous Type.

Assessing the Predictive Value of Plasma FLT3-L Levels for Hematologic Toxicity after Yttrium-90 Ibritumomab Tiuxetan ([ 90 Y]-Zevalin) Given as Consolidation in Patients with Advanced B-Cell Follicular NHL Responding to First Line Therapy.

Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture

Email alerts

ASH Publications

American Society of Hematology

Mobilization of CD8 + Central Memory T-Cells with Enhanced Reconstitution Potential in Mice By a Combination of G-CSF and GMI-1271-Mediated E-Selectin Blockade

Residual Lymphocytes in GM-CSF and IL-15 Differentiated Monocyte-Derived Dendritic Cells Enables Cytotoxic T Lymphocyte Responses.

HuMax-CD20, a Novel Fully Human Anti-CD20 Monoclonal Antibody: Results of a Phase I/II Trial in Relapsed or Refractory Follicular Non-Hodgkins’s Lymphoma.

HuMax-CD4 (Zanolimumab), a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in CD4 + Peripheral T-Cell Lymphoma of Non-Cutaneous Type.

Assessing the Predictive Value of Plasma FLT3-L Levels for Hematologic Toxicity after Yttrium-90 Ibritumomab Tiuxetan ([ 90 Y]-Zevalin) Given as Consolidation in Patients with Advanced B-Cell Follicular NHL Responding to First Line Therapy.

Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only